학술논문

Body Composition and Physical Performance 1 Year After COVID-19.
Document Type
Article
Source
American Journal of Physical Medicine & Rehabilitation. Feb2024, Vol. 103 Issue 2, p124-133. 10p.
Subject
*BODY composition
*COVID-19
*SKELETAL muscle
*CROSS-sectional method
*HEALTH status indicators
*CARDIOPULMONARY system physiology
*COMPARATIVE studies
*BODY movement
*QUALITY of life
*DESCRIPTIVE statistics
*BODY mass index
*LONGITUDINAL method
Language
ISSN
0894-9115
Abstract
Objective: Long-term consequences after COVID-19 include physical complaints, which may impair physical recovery and quality of life. Design: We assessed body composition and physical ability in patients 12 months after COVID-19. Consecutively recruited patients recovering from mild to severe COVID-19 were assessed using bioelectrical impedance analysis, 6-min-walk test, additional scales for physical performance and health-related quality of life. Results: Overall physical recovery was good (i.e., Glasgow Outcome Scale-Extended ≥7 in 96%, Modified Rankin Scale ≤1 in 87%, Eastern Cooperative Oncology Group ≤1 in 99%). Forty-four percent of the 69 patients experienced a significant body mass index increase in the year after COVID-19 (≥1 kg/m² ), whereas skeletal muscle mass index was reduced in only 12%. Patients requiring intensive care treatment (n = 15, 22%) during acute COVID-19 more often had a body mass index increase (P = 0.002), worse 6-min-walk test-performance (P = 0.044), and higher body fat mass (P = 0.030) at the 1-yr follow-up when compared with patients with mild (n = 22, 32%) and moderate (n = 32, 46%) acute COVID-19. Body mass index increase was also more frequent in patients who had no professional rehabilitation (P = 0.014). Conclusions: Although patients with severe COVID-19 had increased body mass index and body fat and performed worse in physical outcome measures 1 yr after COVID-19, overall physical recovery was satisfying. Translating these findings to variants beyond the Alpha strain of severe acute respiratory syndrome coronavirus 2 virus needs further studies. [ABSTRACT FROM AUTHOR]